Scientific deep-dive
Taste Got Better, Not Worse
People on these drugs routinely say food tastes wrong. A trial measured taste objectively, biopsied participants' tongues and scanned their brains, and found taste recognition improved.
People on these drugs routinely say food tastes wrong: metallic, flat, off. A randomized trial measured taste objectively, took biopsies of participants’ tongues, and scanned their brains while they tasted. Taste recognition improved.[1] The two are less contradictory than they look, and the reason explains something patients have been describing for years.
What was measured, and how deeply
Thirty women with polycystic ovary syndrome, averaging 33.7 years and a BMI of 36.4, were randomized to weekly semaglutide 1.0 mg or placebo for 16 weeks. The study then measured taste at three independent levels, which is unusual at this sample size.
- Taste recognition, using 16 strips carrying four concentrations of each of the four basic tastes.
- Gene expression in the tongue, from biopsies.
- Brain activity, by functional MRI, in response both to pictures of food and to a sweet solution dripped onto the tongue.
| Level | Finding |
|---|---|
| Taste recognition score | 11.9 → 14.4 points; treatment difference 2.5 (95% CI 1.7–3.3) |
| Tongue gene expression | Differential RNA expression in EYA, PRMT8, CRLF1, CYP1B1 — genes tied to taste signaling, neural plasticity and taste-bud renewal |
| Brain response | Reduced putamen activation to food images; increased angular gyrus activity to sweet solution after eating (P < .001) |
Three separate kinds of measurement point the same way. For a 30-person trial that is a lot of converging evidence, and it makes the central finding harder to dismiss than a questionnaire result would be.
Why 'better' and 'unpleasant' are both true
Taste recognition improved by 2.5 points against placebo. Nobody measured whether food tasted better.
That resolves the apparent conflict without dismissing anyone. When someone says food tastes strange on this drug, the plausible reading is that their perception has changed rather than dulled, possibly by becoming more acute, and the familiar no longer matches what they expect.
The brain findings fit that. Reduced putamen activation to pictures of food is consistent with lower reward anticipation, or wanting food less on sight. A separate change appeared in response to tasting sweetness after a meal. Wanting less and perceiving more are different systems, and they moved differently.
Enjoyment itself has not been measured directly. Nobody has run a trial asking whether food is more or less pleasant on these drugs, which is the question patients are raising. Smell, which carries most of what people call flavor, is covered in smell changes and body odor on a GLP-1. What patients themselves say about the experience is in eight things patients said.
The design flaw
The gene expression and imaging findings are far less vulnerable to that, because neither is scored by a human judgment in the room. Their agreement with the taste score is what keeps the overall picture credible.
- Thirty participants, all women, all with polycystic ovary syndrome.
- Sixteen weeks, on semaglutide 1.0 mg (the diabetes dose, not the 2.4 mg used for weight).
- No measure of enjoyment, palatability, or whether people changed what they ate as a result.
What it is useful for
Mostly for reassurance of a specific kind. Altered taste on these drugs is a real, physically grounded phenomenon, with measurable changes in the tongue and in the brain. Someone reporting that food is different is describing something with biology behind it.
It also suggests taste changes are unlikely to reflect damage. Differential expression of genes governing taste-bud renewal and neural plasticity fits a system adapting rather than degrading.
Frequently Asked Questions
References
- 1.Jensterle M, Kovac J, Vovk A, et al. Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study The Journal of Clinical Endocrinology and Metabolism. 2025. PMID: 40341357.
- 2.University Medical Centre Ljubljana The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity (NCT04263415) ClinicalTrials.gov. 2023. https://clinicaltrials.gov/study/NCT04263415
Compare the sellers
Related research
Five Hundred Calories at One Lunch
Researchers weighed what 114 people ate at a free-access lunch. Three weeks into tirzepatide they ate 524.6 fewer calories, without any increase in conscious dietary restraint.
6 min read
How Zepbound Works: Tirzepatide's Two Receptors, Appetite and Fat Loss
Zepbound (tirzepatide) switches on the GIP and GLP-1 receptors. Its label says it lowers calorie intake through appetite, slows stomach emptying mostly after the first dose, and improves insulin response. In SURMOUNT-1 body scans, about three-quarters of the weight lost was fat.
8 min read
How Does Phentermine Work? Does It Burn Fat or Suppress Appetite?
Two FDA labels describe phentermine differently: one says it likely lowers appetite through catecholamine release in the hypothalamus, the other says appetite suppression is unproven as its main action. No human trial shows it burns fat, and tolerance sets in within weeks.
6 min read
Does Vaping or Nicotine Cause Weight Loss? What Smokers' Data Show
No study shows vaping causes weight loss. Nicotine modestly curbs appetite and raises calorie burn, but smokers who switched to e-cigarettes gained weight, and quitting adds about 4.7 kg in a year. What the evidence shows, and where GLP-1 drugs fit.
10 min read
Jardiance and Farxiga for Weight Loss: How Much, and Why It Stops
Jardiance and Farxiga cause about 2 kg of weight loss in type 2 diabetes and less without it, and neither is approved for weight. Why appetite cancels most of the sugar lost in urine, the side effects, and how they compare with Wegovy and Zepbound.
10 min read
The Fat Pads in Your Ears
Your eustachian tube is held closed partly by fatty cushions. Two cases describe it staying open after weight loss on a GLP-1, and the adverse event database records the symptom zero times.
6 min read
Where to get GLP-1 online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Luvo Health
Moving between compounded and brand without changing seller
From $179/mo
Get started →Oak
A choice of compounded injections, oral semaglutide and brand-name GLP-1s from one cash-pay checkout
From $100/mo
Get started →Eden
Coverage in all 50 states, which most sellers will not confirm
From $99/mo
Get started →